Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(6/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(6/week)
News
United States
(507/week)
Manufacturing
(335/week)
Energy
(278/week)
Technology
(347/week)
Other Manufacturing
(263/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Rituximab
Apr 23, 2020
Study Underway to Examine the Planned Use of Voraxaze® with Methotrexate in CNS Lymphoma
Mar 12, 2020
AbbVie Receives European Commission Approval of VENCLYXTO® Combination Regimen for Patients with Previously-Untreated Chronic Lymphocytic Leukemia
Mar 04, 2020
Alopexx Oncology Announces Licensing Agreement with Beijing Shenogen Pharma Group for Development and Commercialization of Novel Immunocytokine for the Treatment of B-Cell Lymphomas in China/Asia
Nov 06, 2019
Henlius HLX01 (Rituximab Injection) Wins "Biosimilar Initiative of the Year" at Global Generics & Biosimilars Awards 2019
Nov 04, 2019
Ascentage Pharma and Henlius Form a Combination Therapy Strategic Collaboration
Oct 21, 2019
Sjogren's Syndrome (SS) Market Insights, Epidemiology and Market Forecast, 2028
Sep 27, 2019
FDA approves first treatment for children with rare diseases that cause inflammation of small blood vessels
Sep 20, 2019
Innovent Provides Update on Two Studies of IBI301 (Rituximab Biosimilar) in the Treatment of CD20-positive Lymphoma at Annual Meeting of CSCO
Aug 22, 2019
Amgen And Allergan Announce Positive Top-Line Results From Comparative Clinical Study Of ABP 798, Biosimilar Candidate To Rituxan® (Rituximab)
Aug 12, 2019
Medicines targeting multiple sclerosis and lymphoma are among new specialty drugs available through AllianceRx Walgreens Prime
Jul 12, 2019
Arzerra Drug Overview 2019: A Fully Human Immunoglobulin G1 and High-Affinity Antibody that Targets a Novel Epitope on Cluster of Differentiation 20 (CD20) on the B-Cell Membrane
Jul 12, 2019
Rituxan (rituximab; Biogen/Roche/Chugai/Zenyaku Kogyo) Drug Overview & Product Profiles 2016-2026
Jul 11, 2019
Non-Hodgkin Lymphoma (NHL) Therapeutics Market to Record a CAGR of 7.4% During 2019-2024
Jun 27, 2019
NMPA Accepts New Drug Application for IBI301, a Biosimilar Product Candidate of Rituximab (MabThera/Rituxan)
Jun 03, 2019
MEI Pharma Presents Updated Clinical Data from the ME-401 Monotherapy and in Combination with Rituximab Phase 1b study in Patients with Follicular Lymphoma at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting
May 30, 2019
Rare Disease Patient Candace Lerman Calls for Clinical Trials on Off-Label Treatments; Launches ITP Patient Driven Research Initiative
May 21, 2019
Nordic Nanovector: Archer-1 Phase 1b Betalutin®/Rituximab Combination Trial Advances to Next Cohort
May 07, 2019
Two Clinical Studies with IBI301, a Biosimilar Candidate to Rituximab, Met Primary Endpoints
Mar 26, 2019
Hansa Biopharma Receives Ethics and Regulatory Clearance to Start Phase 2 Study of Imlifidase in Acute Antibody Mediated Rejection in Kidney Transplantation
Mar 06, 2019
Reducing B Cells with Modified CAR T Cells is an Effective Treatment of Experimental Lupus
Page 1
››
Latest News
Apr 20, 2024
nVent Electric plc to Release First Quarter 2024 Financial Results and Host Earnings Conference Call on...
Apr 20, 2024
Activated Carbon Global Strategic Business Report 2024-2030: Led by China, Asia-Pacific Enjoys Commanding...
Apr 20, 2024
AeroMech Announces RVSM Certification Program for Piper M700 Fury
Apr 20, 2024
Divert Announces Purchase of New Site in Lexington, North Carolina for Future Integrated Diversion &...
Apr 20, 2024
Scepter Simplifies Refueling with the Flip of a Switch
Apr 20, 2024
Global Large Caliber Ammunition Market Analysis and Forecasts, 2023-2024 and 2033: Smart Ammunition...
Apr 20, 2024
Arcline Completes Acquisition of Kaman
Apr 20, 2024
L3Harris Announces Quarterly Dividend
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events